Aucta is a global brand that creates better products from proven molecules.
About
CPhI North America CPhI North America
Industry Trade Show
Not Confirmed
20-22 May, 2025
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Attending
28-30 October, 2025
Industry Trade Show
Attending
05-09 December, 2025
CONTACT DETAILS
Digital content 
CORPORATE CONTENT #SupplierSpotlight
NEWS #PharmaBuzz
03 Feb 2025
// FDA
11 Mar 2024
// DRUG STORE NEWS
26 Feb 2024
// PR NEWSWIRE
05 Dec 2022
// PR NEWSWIRE
01 Dec 2022
// PRNEWSWIRE
30 Nov 2022
// FDA
Drugs in Development
Lead Product(s) : Lacosamide
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Aucta Launches MOTPOLY XR, the First Once-Daily Lacosamide Formulation
Details : Motpoly (lacosamide) is an antiepileptic drug that works by blocking sodium channel alpha subunit. It is being evaluated for partial-onset seizures in adults and in pediatric patients.
Product Name : Motpoly XR
Product Type : Controlled Substance
Upfront Cash : Inapplicable
February 26, 2024
Lead Product(s) : Oxcarbazepine
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Aucta Announced FDA Approval of A Generic Version of Trileptal®(oxcarbazepine) Oral Suspension
Details : Oxcarbazepine produce blockade of voltage-sensitive sodium channels, resulting in stabilization of hyperexcited neural membranes, inhibition of repetitive neuronal firing, and diminution of propagation of synaptic impulses. It is indicated to treat parti...
Product Name : Trileptal-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 12, 2022
Lead Product(s) : Formoterol Fumarate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Aucta Announces FDA Approval Of A Generic Version Of Perforomist® (formoterol fumarate) Inhalatio...
Details : Formoterol Fumarate is a long-acting bronchodilator used as a long-term treatment to prevent or decrease wheezing and trouble breathing caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchiti...
Product Name : Perforomist-Generic
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
January 12, 2022
Lead Product(s) : Deferasirox
Therapeutic Area : Hematology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Oakrum Pharma, LLC
Deal Size : Inapplicable
Deal Type : Inapplicable
Oakrum Pharma and Aucta Pharma Announce U.S. FDA Approval of Generic Version of JADENU® Sprinkle ...
Details : JADENU (deferasirox) tablets for oral use and JADENU® Sprinkle (deferasirox) granules are indicated for the treatment of chronic iron overload due to blood transfusions (transfusional hemosiderosis) in patients 2 years of age and older.
Product Name : Jadenu
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 22, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;INHALATION
Brand Name : ARFORMOTEROL TARTRATE
Dosage Strength : EQ 0.015MG BASE/2ML
Packaging :
Approval Date : 2025-02-03
Application Number : 218380
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : GRANULE;ORAL
Brand Name : DEFERASIROX
Dosage Strength : 180MG
Packaging :
Approval Date : 2021-03-09
Application Number : 214559
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : GRANULE;ORAL
Brand Name : DEFERASIROX
Dosage Strength : 90MG
Packaging :
Approval Date : 2021-03-09
Application Number : 214559
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : GRANULE;ORAL
Brand Name : DEFERASIROX
Dosage Strength : 360MG
Packaging :
Approval Date : 2021-03-09
Application Number : 214559
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Oral Granule
Brand Name :
Dosage Strength : 360MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Inhalation Solution
Brand Name :
Dosage Strength : 20MCG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info : RX
Registration Country : USA
Dosage Form : CAPSULE, EXTENDED RELEAS...
Brand Name : MOTPOLY XR
Dosage Strength : 150MG
Packaging :
Approval Date : 2023-05-04
Application Number : 216185
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : CAPSULE, EXTENDED RELEAS...
Brand Name : MOTPOLY XR
Dosage Strength : 100MG
Packaging :
Approval Date : 2023-05-04
Application Number : 216185
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : CAPSULE, EXTENDED RELEAS...
Brand Name : MOTPOLY XR
Dosage Strength : 200MG
Packaging :
Approval Date : 2023-05-04
Application Number : 216185
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Extended Release Capsule
Brand Name : Motpoly XR
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
RLD : No
TE Code : AN
Dosage Form : SOLUTION; INHALATION
Proprietary Name : ARFORMOTEROL TARTRATE
Dosage Strength : EQ 0.015MG BASE/2ML
Approval Date : 2025-02-03
Application Number : 218380
RX/OTC/DISCN : RX
RLD : No
TE Code : AN
RLD : No
TE Code : AB
Dosage Form : GRANULE; ORAL
Proprietary Name : DEFERASIROX
Dosage Strength : 90MG
Approval Date : 2021-03-09
Application Number : 214559
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : GRANULE; ORAL
Proprietary Name : DEFERASIROX
Dosage Strength : 180MG
Approval Date : 2021-03-09
Application Number : 214559
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AB
Dosage Form : GRANULE; ORAL
Proprietary Name : DEFERASIROX
Dosage Strength : 360MG
Approval Date : 2021-03-09
Application Number : 214559
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : MOTPOLY XR
Dosage Strength : 100MG
Approval Date : 2023-05-04
Application Number : 216185
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : MOTPOLY XR
Dosage Strength : 150MG
Approval Date : 2023-05-04
Application Number : 216185
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
Dosage Form : CAPSULE, EXTENDED RELEASE; ORA...
Proprietary Name : MOTPOLY XR
Dosage Strength : 200MG
Approval Date : 2023-05-04
Application Number : 216185
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code : AB
Dosage Form : SUSPENSION; ORAL
Proprietary Name : OXCARBAZEPINE
Dosage Strength : 300MG/5ML
Approval Date : 2022-11-30
Application Number : 215332
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : No
TE Code : AA
Dosage Form : FOR SOLUTION; ORAL
Proprietary Name : VIGADRONE
Dosage Strength : 500MG/PACKET
Approval Date : 2018-06-21
Application Number : 210196
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
Listed Dossiers
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Oral Granule
Brand Name :
Dosage Strength : 360MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Inhalation Solution
Brand Name :
Dosage Strength : 20MCG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Extended Release Capsule
Brand Name : Motpoly XR
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Oral Suspension
Brand Name :
Dosage Strength : 300MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Oral Solution
Brand Name : Vigadrone
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
Aucta Pharmaceuticals
Aucta is a global brand that creates better products from proven molecules.
